BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10450992)

  • 1. Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands.
    Jones AB; Acton JJ; Adams AD; Yuen W; Nichols EA; Schwartz CD; Wicker LS; Hermes JD
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2115-8. PubMed ID: 10450992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate.
    Jones AB; Acton JJ; Rivetna MN; Cummings RT; Cubbon RM; Nichols EA; Schwartz CD; Wicker LS; Hermes JD
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2109-14. PubMed ID: 10450991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands.
    Meyer VS; Drews O; Günder M; Hennenlotter J; Rammensee HG; Stevanovic S
    J Proteome Res; 2009 Jul; 8(7):3666-74. PubMed ID: 19415920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein.
    McFarland BJ; Katz JF; Sant AJ; Beeson C
    J Mol Biol; 2005 Jul; 350(1):170-83. PubMed ID: 15921691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and evaluation of MHC class II binding peptides.
    de Haan EC; Wauben MH; Grosfeld-Stulemeyer MC; Moret EE
    Biologicals; 2001; 29(3-4):289-92. PubMed ID: 11851330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes.
    McFarland BJ; Beeson C; Sant AJ
    J Immunol; 1999 Oct; 163(7):3567-71. PubMed ID: 10490947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noble metals strip peptides from class II MHC proteins.
    De Wall SL; Painter C; Stone JD; Bandaranayake R; Wiley DC; Mitchison TJ; Stern LJ; DeDecker BS
    Nat Chem Biol; 2006 Apr; 2(4):197-201. PubMed ID: 16505807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERp57 interacts with conserved cysteine residues in the MHC class I peptide-binding groove.
    Antoniou AN; Santos SG; Campbell EC; Lynch S; Arosa FA; Powis SJ
    FEBS Lett; 2007 May; 581(10):1988-92. PubMed ID: 17467700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide length-based prediction of peptide-MHC class II binding.
    Chang ST; Ghosh D; Kirschner DE; Linderman JJ
    Bioinformatics; 2006 Nov; 22(22):2761-7. PubMed ID: 17000752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of peptide-MHC class II interaction.
    Fleckenstein B; Jung G; Wiesmüller KH
    Semin Immunol; 1999 Dec; 11(6):405-16. PubMed ID: 10625594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
    Yaneva R; Springer S; Zacharias M
    Biopolymers; 2009 Jan; 91(1):14-27. PubMed ID: 18767126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S.
    Thurmond RL; Beavers MP; Cai H; Meduna SP; Gustin DJ; Sun S; Almond HJ; Karlsson L; Edwards JP
    J Med Chem; 2004 Sep; 47(20):4799-801. PubMed ID: 15369380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Bayesian neural network models of MHC class II peptide binding.
    Burden FR; Winkler DA
    J Mol Graph Model; 2005 Jun; 23(6):481-9. PubMed ID: 15878832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-binding motifs for the I-Ad MHC class II molecule: alternate pH-dependent binding behavior.
    Chaves FA; Richards KA; Torelli A; Wedekind J; Sant AJ
    Biochemistry; 2006 May; 45(20):6426-33. PubMed ID: 16700553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship of peptides binding to the class II major histocompatibility complex molecule Aq associated with autoimmune arthritis.
    Holm L; Frech K; Dzhambazov B; Holmdahl R; Kihlberg J; Linusson A
    J Med Chem; 2007 May; 50(9):2049-59. PubMed ID: 17425295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A revised model for invariant chain-mediated assembly of MHC class II peptide receptors.
    Koch N; McLellan AD; Neumann J
    Trends Biochem Sci; 2007 Dec; 32(12):532-7. PubMed ID: 17980601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bound peptide-dependent thermal stability of major histocompatibility complex class II molecule I-Ek.
    Saito K; Oda M; Sarai A; Azuma T; Kozono H
    Biochemistry; 2004 Aug; 43(31):10186-91. PubMed ID: 15287746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class I major histocompatibility complexes loaded by a periodate trigger.
    Rodenko B; Toebes M; Celie PH; Perrakis A; Schumacher TN; Ovaa H
    J Am Chem Soc; 2009 Sep; 131(34):12305-13. PubMed ID: 19655751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.